Abdalla MMI (2024) Insulin resistance as the molecular link between diabetes and Alzheimer’s disease. World J Diabetes 15(7):1430–1447

Article  PubMed  PubMed Central  Google Scholar 

Ajmone-Cat MA, Bernardo A, Greco A, Minghetti L (2010) Non-steroidal anti-inflammatory drugs and brain inflammation: effects on microglial functions. Pharmaceuticals (Basel) 3(6):1949–1965. https://doi.org/10.3390/ph3061949

Article  CAS  PubMed  Google Scholar 

Atlante A, Amadoro G, Latina V, Valenti D (2022) Therapeutic potential of targeting mitochondria for Alzheimer’s disease treatment. J Clin Med 11(22):6742

Article  CAS  PubMed  PubMed Central  Google Scholar 

Avitan I, Halperin Y, Saha T et al (2021) Towards a consensus on Alzheimer’s disease comorbidity?? J Clin Med 10(19):4360. https://doi.org/10.3390/jcm10194360

Article  CAS  PubMed  PubMed Central  Google Scholar 

Busche MA, Hyman BT (2020) Synergy between amyloid-β and tau in Alzheimer’s disease. Nat Neurosci 23(10):1183–1193. https://doi.org/10.1038/s41593-020-0687-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao F, Yang F, Li J, Guo W, Zhang C, Gao F, Sun X, Zhou Y, Zhang W (2024) The relationship between diabetes and the dementia risk: a meta-analysis. Diabetol Metab Syndr 16(1):101. https://doi.org/10.1186/s13098-024-01346-4

Article  PubMed  PubMed Central  Google Scholar 

Carey A, Parodi-Rullan R, Vazquez-Torres R, Canepa E, Fossati S (2024) Homocysteine potentiates amyloid β-induced death receptor 4- and 5-mediated cerebral endothelial cell apoptosis, blood–brain barrier dysfunction, and angiogenic impairment. Aging Cell 23(5):e14106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chakraborty A, Sami SA, Marma KKS (2021) A comprehensive review on RAGE-facilitated pathological pathways connecting Alzheimer’s disease, diabetes mellitus, and cardiovascular diseases. Egypt J Intern Med 33:47

Article  Google Scholar 

Chakravorty A, Jetto CT, Manjithaya R (2019) Dysfunctional mitochondria and mitophagy as drivers of Alzheimer’s disease pathogenesis. Front Aging Neurosci 11:311

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang R, Trushina E, Zhu K et al (2022) Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer’s disease. Alzheimers Dement 19(2):518–531

Article  PubMed  Google Scholar 

Cross K, Vetter SW, Alam Y, Hasan MZ, Nath AD, Leclerc E (2024) Role of the receptor for advanced glycation end products (RAGE) and its ligands in inflammatory responses. Biomolecules 14(12):1550

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cruz JVR, Batista C, Diniz LP, Mendes FA (2023) The role of astrocytes and blood–brain barrier disruption in Alzheimer’s disease. Neuroglia. https://doi.org/10.3390/neuroglia4030015

Article  Google Scholar 

Dabour MS, George MY, Daniel MR, Blaes AH, Zordoky BN (2024) The cardioprotective and anticancer effects of SGLT2 inhibitors: JACC: cardiooncology state-of-the-art review. JACC: CardioOncology 6(2):159–182

PubMed  PubMed Central  Google Scholar 

Dan L, Hao Y, Li J, Wang T, Zhao W, Wang H, Qiao L, Xie P (2024) Neuroprotective effects and possible mechanisms of berberine in animal models of alzheimer’s disease: a systematic review and meta-analysis. Front Pharmacol 14:1287750 (PMID: 38259291; PMCID: PMC10800531)

Article  PubMed  PubMed Central  Google Scholar 

Dash UC, Bhol NK, Swain SK, Samal RR, Nayak PK, Raina V, Panda SK, Kerry RG, Duttaroy AK, Jena AB (2025) Oxidative stress and inflammation in the pathogenesis of neurological disorders: mechanisms and implications. Acta Pharm Sin B 15(1):15–34

Article  CAS  PubMed  Google Scholar 

de la Monte SM, Wands JR (2008) Alzheimer’s disease is type 3 diabetes—evidence reviewed. J Diabetes Sci Technol 2(6):1101–1113. https://doi.org/10.1177/193229680800200619

Article  PubMed  PubMed Central  Google Scholar 

El Idrissi A, del Alonso A C (2022) Pathological human Tau induces alterations in the brain insulin signaling cascade. Front NeuroSci 16:805046

Article  PubMed  PubMed Central  Google Scholar 

Eyre B, Shabir O, Lee L, Francis S, Howarth C, Berwick J (2022) How does Alzheimer’s disease, atherosclerosis, and comorbid Alzheimer’s disease and atherosclerosis impact neurovascular function? Alzheimers Dement. https://doi.org/10.1002/alz.069266

Article  Google Scholar 

Femminella GD et al (2019) Assessing the impact of GLP-1 analog liraglutide on alzheimer’s dementia: a pilot study. Alzheimer’s Res Therapy 11(1):1–9

Google Scholar 

Gao F, Du W, Guo C, Geng P, Liu W, Jin X (2024) α7nACh receptor: a promising target to reduce BBB damage by regulating inflammation and autophagy after ischemic stroke. Biomed Pharmacother 179:117337

Article  CAS  PubMed  Google Scholar 

Garcia-Casas P, Rossini M, Filadi R, Pizzo P (2023) Mitochondrial ca²⁺ signaling and Alzheimer’s disease: too much or too little? Cell Calcium 113:102757

Article  CAS  PubMed  Google Scholar 

Godoy JA, Ríos JA, Picón-Pagès P, Herrera-Fernández V, Swaby B, Crepin G, Vicente R, Fernández-Fernández JM, Muñoz FJ (2021) Mitostasis, calcium and free radicals in health, aging and neurodegeneration. Biomolecules 11(7):1012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guan Y, Li J, Gu Y, Ji X (2023) Effects of hypoxia on cerebral microvascular angiogenesis: benefits or damages? Aging Dis 14:370–385

PubMed  PubMed Central  Google Scholar 

Hamzé R, Delangre E, Tolu S, Moreau M, Janel N, Bailbe D, Movassat J (2022) Type 2 diabetes mellitus and Alzheimer’s disease: shared molecular mechanisms and potential common therapeutic targets. Int J Mol Sci 23(23):15287

Article  PubMed  PubMed Central  Google Scholar 

Heimke M, Lenz F, Rickert U, Lucius R, Cossais F (2022) Anti-inflammatory properties of the SGLT2 inhibitor empagliflozin in activated primary microglia. Cells 11(19):3107

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heneka MT, Gauthier S, Chandekar SA et al (2025) Neuroinflammatory fluid biomarkers in patients with Alzheimer’s disease: a systematic literature review. Mol Psychiatry. https://doi.org/10.1038/s41380-025-02939-9

Article  PubMed  PubMed Central  Google Scholar 

Hobday AL, Parmar MS (2021) The link between diabetes mellitus and tau hyperphosphorylation: implications for risk of Alzheimer’s disease. Cureus 13(9):e18362

PubMed  PubMed Central  Google Scholar 

Iheagwam FN, Joseph AJ, Adedoyin ED, Iheagwam OT, Ejoh SA (2025) Mitochondrial dysfunction in diabetes: shedding light on a widespread oversight. Pathophysiology 32(1):9

Article  PubMed  PubMed Central  Google Scholar 

Jadiya P, Kaye SD, Raghav D, Kadam A, Elrod JW, Tomar D (2024) Preserving bioenergetics through mitochondrial calcium homeostasis in Alzheimer’s disease. J Biol Chem 300(3):106420

Article  Google Scholar 

Kalani A, Chaturvedi P, Brunetti D, Kalani K (2023) Editorial: mitochondrial therapy in neurodegeneration. Front Pharmacol 14:1144093

Article  PubMed  PubMed Central  Google Scholar 

Karthikeyan AAS, Singh S, Kukreti R, Saso L, Kukreti S (2022) Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes. Molecules 27(3):950

Article  Google Scholar 

Kciuk M, Kruczkowska W, Gałęziewska J, Wanke K, Kałuzińska-Kołat Ż, Aleksandrowicz M, Kontek R (2024) Alzheimer’s disease as type 3 diabetes: understanding the link and implications. Int J Mol Sci 25(22):11955

Article